SAKK is delighted to partner again with Novartis in the organization of NORD 2021. 

The main objective of the Swiss NORD meeting is to provide a forum for Swiss investigators to interact with Novartis research and development colleagues as well as the local medical department in order to discuss  current and future treatment approaches and potential projects in cancer therapy and facilitate collaborations between different stakeholders. 

We will start with a plenary session, where an overview on recent and future directions in cancer research will be given by representatives from Novartis and SAKK. Afterwards important questions around preclinical, translational, as well as clinical research and diagnostics within various disease areas will be addressed in four different workshops (please see the flyer below). These interactive discussions will hopefully pave the way for new and deeper collaborations that lead to advances in cancer treatment.

You can already register now! Please send your name and institution to swissonco.medical@novartis.com, highlighting your 1st and 2nd priority for the workshops (please see the flyer below). 

We are looking forward to hopefully welcoming you at the Basel Campus in person soon.